M iddle E ast - WHO EMRO

4 downloads 188 Views 988KB Size Report
Jan 6, 2014 - O u tb reak R esp o n se. Supplem entary Im m unization A ctivities. 5. N. ID. SN. ID. C. H. D. Ja n. F e
M i d d l e

E a s t

P o l i o Te c h n i c a l B u l l e t i n EMR: Egypt, Iraq, Jordan, Lebanon, Syria, West Bank and Gaza Strip EUR: Turkey Data in WHO as of 31 December 2013 (Week 1) – No.3

Situation Update 6 January 2014: The total number of confirmed wild poliovirus cases remains at 17. There were no new wild poliovirus cases reported since the last technical bulletin. The polio outbreak was declared by the Minister of Health of the Syrian Arab Republic on 28 October 2013 with 13 confirmed cases from Deir-Al-Zour, additional cases have also been confirmed from Aleppo and Rural Damascus. Genetic sequencing indicates that the virus has been circulating in the region for nearly a year. It is linked to virus detected in environmental samples from Egypt in December 2012, which is closely linked to strains detected from environmental samples in Israel since February 2013, and the West Bank and Gaza Strip since July 2013.

New cases – Summary: New cases this week: none Location / Date of onset: none Outbreak – Summary: Total number of cases: 17 (in Syria) Most recent case: Deir-Al-Zour, Mayadeen / 08-Oct-13

Given the current situation across the region with frequent population movements and concerns about polio immunization rates and AFP surveillance indicators in key areas, the risk of further international spread of wild poliovirus is considered to be high. Coordinated supplementary immunization and surveillance activities have been planned throughout the region.

Index case: Aleppo, Fardous / 14-Jul-13

.

Duration of outbreak: 12 weeks Extent of outbreak: 3 governorates/ 3 districts (in Syria)

SIA – Summary: Number of SIAs since Index case: 2 (2 NIDs) Number of SIAs since last case: 2 (2 NIDs)

1

Summary information as of 31 December 2013

AFP case information, 2013 Syria

Egypt

Iraq

Jordan

Lebanon

West Bank and Gaza Strip

Turkey

NP AFP cases

NP AFP cases

NP AFP cases

NP AFP cases

WPV cases

NP AFP cases

NP AFP cases

NP AFP cases

Nb 0 13 3 1 0 0 17

% 0% 76% 18% 6% 0% 0%

Nb 5 38 32 35 15 4 129

% 4% 29% 25% 27% 12% 3%

Nb 27 370 345 187 59 0 988

% 3% 37% 35% 19% 6% 0%

Nb 19 115 166 90 36 0 426

% 4% 27% 39% 21% 8% 0%

Nb 2 5 15 6 4 1 33

% 6% 15% 45% 18% 12% 3%

Nb 1 4 14 8 4 0 31

% 3% 13% 45% 26% 13% 0%

Nb 0 11 12 5 9 0 37

% 0% 30% 32% 14% 24% 0%

Nb 4 27 65 58 59 3 216

% 2% 13% 30% 27% 27% 1%

0 Dose 1-2 Doses 3 Doses 4+ Doses Unknown TOTAL

9 6 1 1 0 17

53% 35% 6% 6% 0%

17 14 9 83 6 129

13% 11% 7% 64% 5%

0 17 13 949 9 988

0% 2% 1% 96% 1%

5 25 40 332 24 426

1% 6% 9% 78% 6%

0 0 1 23 9 33

0% 0% 3% 70% 27%

2 2 5 18 4 31

6% 6% 16% 58% 13%

0 0 0 36 1 37

0% 0% 0% 97% 3%

20 73 9 114 0 216

9% 34% 4% 53% 0%

M F

10 7 17

59% 41%

72 57 129

56% 44%

569 419 988

58% 42%

247 179 426

58% 42%

21 12 33

64% 36%

26 5 31

84% 16%

14 23 37

38% 62%

128 88 216

59% 41%

Age 0-5 months 6-23 months 24-59 months 60-119 months 120-179 months 180+ months TOTAL

Vaccination status

Gender

TOTAL

Surveillance indicators, 2010-2013 Country / Territory Egypt

Iraq

Jordan

Lebanon

Syrian Arab Republic

Turkey

West Bank and Gaza Strip

Year

AFP cases reported

Non-polio AFP rate

AFP cases with adequate specimens (%)

2010 2011 2012 2013 2010 2011 2012 2013 2010 2011 2012 2013 2010 2011 2012 2013 2010 2011 2012 2013 2010 2011 2012 2013 2010 2011 2012 2013

1151 1023 1022 988 489 530 467 426 40 30 34 33 19 22 24 31 194 168 109 146 215 196 172 216 15 17 21 37

4.5 4.0 3.9 3.1 4.0 4.3 3.8 3.0 1.8 1.4 1.5 1.4 1.7 2.0 2.2 2.8 2.6 2.3 1.4 1.3 1.1 1.0 0.9 1.0 0.9 1.1 1.3 2.2

95 93 92 91 87 89 90 84 95 97 85 89 47 45 50 40 95 93 84 70 74 81 81 74 100 100 95 94

Targets: NP AFP rate: ≥2/100,000 pop